Back to „Institute of Immunology”

Zoonosenplattform

external funds raised

News from

In a pilot application in February 2019, PD Dr. Uwe Müller received approval for a study to investigate the allergenicity of cryptococcus species and their proteins.

Precision cut lung slice of an interleukin-33 reporter system in contact with E2-Crimson-expressing cryptococci. The image was taken in the Core Unit BCF. Photo: Johannes Kacza and Uwe Müller

The study has a duration and has been approved by the expert panel of the National Zoonoses Platform. It is currently in the review phase at DLR on behalf of the BMBF. The start of the study is scheduled for 01.09.2019.